YE7-20914-10406
3 vaccinations
4 coded responses
7 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 803 / CO
- Registered
- 2021-10-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-10-05
Registered in v-safe
-
2021-10-05
Dose 3 — Pfizer-BioNTech
- 2021-10-05
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-07
Survey response — days 1–6 daily, dose 3MedDRA: Fatigue, Injection site pain — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Injection site pain anjection site pain and fatigue are much improved from yesterdayMedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Survey response — day 14, dose 3MedDRA: Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Slightly off balance but I think this started prior to vaccineMedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Report sent to call center — day 14, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-22
-
2021-10-27
Survey response — day 21, dose 3MedDRA: Cough, Exposure to communicable disease, Fatigue, Impaired work ability, Pain, Pyrexia, SARS-CoV-2 test — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Onset 3 days ago : Fatigue, body aches dry cough, mild fever: air travel prior to onset w exposure to young grandchildren with URI. covid test today. Had flu vaccine.borderline "unable to attend work"MedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
-
2021-11-16
Survey response — day 42, dose 3MedDRA: Exposure to SARS-CoV-2, Fatigue, Headache, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Headache fatigue sore throat fever pos covid test yesterday after exposure · Healthcare visit (other): Ab infusionMedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Report sent to call center — day 42, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2021-11-17
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | No |
| 2 | 2021-01-12 | Pfizer-BioNTech | No |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-19 | Successful | Does not wish to fill out VAERS report |
| 2021-11-16 | Successful 2021-11-17 |
Does not wish to fill out VAERS report |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Injection site pain anjection site pain and fatigue are much improved from yesterday
Release 10 — day 14, dose 3
Symptoms: Slightly off balance but I think this started prior to vaccine
Release 10 — day 21, dose 3
Symptoms: Onset 3 days ago : Fatigue, body aches dry cough, mild fever: air travel prior to onset w exposure to young grandchildren with URI. covid test today. Had flu vaccine.borderline "unable to attend work"
Release 10 — day 42, dose 3
Symptoms: Headache fatigue sore throat fever pos covid test yesterday after exposure
Healthcare visit (other): Ab infusion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Exposure to communicable disease | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release